Modalis Therapeutics Corporation 4883.T Stock
Modalis Therapeutics Corporation Price Chart
Modalis Therapeutics Corporation 4883.T Financial and Trading Overview
| Modalis Therapeutics Corporation stock price | 68 JPY |
| Previous Close | 309 JPY |
| Open | 315 JPY |
| Bid | 312 JPY x N/A |
| Ask | 314 JPY x N/A |
| Day's Range | 303 - 319 JPY |
| 52 Week Range | 239 - 570 JPY |
| Volume | 710.3K JPY |
| Avg. Volume | 512.42K JPY |
| Market Cap | 9.42B JPY |
| Beta (5Y Monthly) | 0.068818 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -72.95 JPY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 900 JPY |
4883.T Valuation Measures
| Enterprise Value | 6.64B JPY |
| Trailing P/E | N/A |
| Forward P/E | 14.820075 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | Infinity |
| Price/Book (mrq) | 3.5652046 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.359 |
Trading Information
Modalis Therapeutics Corporation Stock Price History
| Beta (5Y Monthly) | 0.068818 |
| 52-Week Change | -22.36% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 570 JPY |
| 52 Week Low | 239 JPY |
| 50-Day Moving Average | 272.08 JPY |
| 200-Day Moving Average | 330.1 JPY |
4883.T Share Statistics
| Avg. Volume (3 month) | 512.42K JPY |
| Avg. Daily Volume (10-Days) | 699.42K JPY |
| Shares Outstanding | 30.09M |
| Float | 15.08M |
| Short Ratio | N/A |
| % Held by Insiders | 30.01% |
| % Held by Institutions | 32.45% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -30.94% |
| Return on Equity (ttm) | -71.90% |
Income Statement
| Revenue (ttm) | 0 JPY |
| Revenue Per Share (ttm) | 0 JPY |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 40M JPY |
| EBITDA | -1975500032 JPY |
| Net Income Avi to Common (ttm) | -2796000000 JPY |
| Diluted EPS (ttm) | -103.95 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.71B JPY |
| Total Cash Per Share (mrq) | 89.56 JPY |
| Total Debt (mrq) | 0 JPY |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 14.085 |
| Book Value Per Share (mrq) | 87.793 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Modalis Therapeutics Corporation
| Country | Japan |
| State | N/A |
| City | Tokyo |
| Address | Y’s Building |
| ZIP | 103-0026 |
| Phone | N/A |
| Website | https://modalistx.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 36 |
Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. It is developing therapies fo genetic diseases using its proprietary CRISPR-GNDM technology that enables to control gene expressions through modulating the switch (epigenetics of a specific locus. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corporation was founded in 2016 and is headquartered in Tokyo, Japan.
Q&A For Modalis Therapeutics Corporation Stock
What is a current 4883.T stock price?
Modalis Therapeutics Corporation 4883.T stock price today per share is 68 JPY.
How to purchase Modalis Therapeutics Corporation stock?
You can buy 4883.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Modalis Therapeutics Corporation?
The stock symbol or ticker of Modalis Therapeutics Corporation is 4883.T.
Which industry does the Modalis Therapeutics Corporation company belong to?
The Modalis Therapeutics Corporation industry is Drug Manufacturers-Specialty & Generic.
How many shares does Modalis Therapeutics Corporation have in circulation?
The max supply of Modalis Therapeutics Corporation shares is 34.19M.
What is Modalis Therapeutics Corporation Price to Earnings Ratio (PE Ratio)?
Modalis Therapeutics Corporation PE Ratio is now.
What was Modalis Therapeutics Corporation earnings per share over the trailing 12 months (TTM)?
Modalis Therapeutics Corporation EPS is -72.95 JPY over the trailing 12 months.
Which sector does the Modalis Therapeutics Corporation company belong to?
The Modalis Therapeutics Corporation sector is Healthcare.